For example, in colon of patients with inflammatory bowel disease, the mRNA expression levels of SLCO4A1, and also other SLCOs, e.g., SLCO2B1 were upregulated, while the expression of transporters from other families was downregulated (Wojtal et al., 2009). This evidence concerns the gene SLCO2B1 and inflammatory bowel disease.